4. Discussion
Our work adds evidence for the role of non-amyloidogenic and amyloidogenic pathways, specifically of secretases in the aging process. In addition, to our knowledge, this is the first study evaluating TACE activity in healthy aged brains. In this context, we observed a diminished -secretase activity, specifically TACE (ADAM17). Consistent with our results, lower soluble APP (sAPP) levels, a TACE-derived product, have been found in cerebrospinal fluid (CSF) of 23-month-old rats [19]. Moreover, individuals with Alzheimer’s disease present low sAPP levels in the CSF suggesting reduced TACE-dependent -secretase activity [40,41]. Taken that sAPP appears to have beneficial functions including neuroprotection, neurotrophism and neurogenesis [19,42], it is possible to suppose that reduced TACE activity observed here in aged prefrontal cortices and hippocampus might be implicated in their susceptibility to neurodegenerative disorders. We can suggest that the memory impairment in aged rats, as evaluated by an inhibitory avoidance test, may be related to cortical TACE activity, since this parameter was reduced in prefrontal cortices of 21-and 26-month-old rats while in hippocampus this reduction was observed only in oldest rats (26-month-old rats). In accordance, Anderson et al. [19] showed the involvement of sAPP levels in the cerebrospinal fluid (CSF) with better spatial cognitive performance in aged rats. Our data support the idea that decreases in cortical -secretase (TACE)-mediated cleavage of APP, a non-amyloidogenic pathway, may be partly involved in the agingrelated aversive memory decline. In add